| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |